Therefore, this study focused on investigating the correlation of tumor markers encompassing CEA, CA15-3, and CA125 levels with molecular subtypes to improve the prognostic prediction for breast cancer and inform the appropriate therapy. This evidence concerns the gene MUC16 and breast cancer.